# Topical Timolol Gel for the Treatment of Infantile Hemangiomas

> **NCT02145884** · PHASE2 · COMPLETED · sponsor: **Rady Children's Hospital, San Diego** · enrollment: 26 (actual)

## Conditions studied

- Hemangioma

## Interventions

- **DRUG:** timolol maleate 0.5% gel

## Key facts

- **NCT ID:** NCT02145884
- **Lead sponsor:** Rady Children's Hospital, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2016-10
- **Final completion:** 2016-11
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2017-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02145884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02145884, "Topical Timolol Gel for the Treatment of Infantile Hemangiomas". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02145884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*